Disruption of IRE1α through its kinase domain attenuates multiple myeloma

Avi Ashkenazi(Molecular Oncology (United States)), Amy Heidersbach, Wendy Sandoval(Abterra Biosciences (United States)), Klára Tótpál, Heidi Ackerly Wallweber, Yung-Chia Ariel Chen, Anna Shemorry, Justin Q. Ly, Kevin Clark(Google (United States)), Weiru Wang(Guangzhou Institute of Geochemistry), Robby M. Weimer(Sunesis (United States)), Joachim Rudolph, Daniel W. Sherbenou(University of Colorado Anschutz Medical Campus), Alvin Gogineni(Angiogenesis Foundation), Maureen H. Beresini, Mike Reichelt, Michael J. VanWyngarden(University of Colorado Cancer Center), David A. Lawrence(Albany College of Pharmacy and Health Sciences), Tom De Bruyn, Benjamin Haley, Steven T. Laing, Maria Lorenzo, Patricia Gomez‐Bougie(Centre National de la Recherche Scientifique), Mark Merchant(Revolution Medicines (United States)), Scot A. Marsters, Diego Acosta‐Alvear(Santa Barbara City College), Adrien Le Thomas, David Kan, Peter Walter(Bay Institute), Dong Hun Lee(Seoul National University), Min Lu(Shanghai Jiao Tong University), Marie-Gabrielle Braun, Susan Kaufman(Genesys (United States)), Martine Amiot(Université Paris Cité), Ehud Segal
Proceedings of the National Academy of Sciences
August 1, 2019
Cited by 115


Related Papers